Page URL: https://www.bionews.org.uk/page_94081

'Gene signature' predicts chemotherapy survival

22 April 2013
Appeared in BioNews 701

Scientists have identified an eight-gene 'signature' that can predict patients' response to chemotherapy, according to a study published in journal BMC Medicine.

The researchers, from Academia Sinica and the National Taiwan University College of Medicine, looked at the effect of 99 different chemotherapy drugs on 60 cancer cell lines, representing leukaemia, melanoma, and breast cancer, among others.

They looked at the pattern of activation of these genes in each of the cell lines and found that eight genes in particular influenced the cells' response to the drugs.

Using this 'gene signature', the researchers were able to predict which people would have a better chance of surviving after chemotherapy without relapse. The researchers calculated whether patients had an above-average risk of relapse following chemotherapy by studying which of these eight genes were expressed. Patients with a low score were found to have longer relapse-free survival times after chemotherapy.

Professor Ker-Chau Li, who conducted the research, said: 'Our study found eight genes which were involved in invasion, and the relative activation of these genes correlated to chemotherapy outcome'.

The finding hints at the possibility of personalised cancer treatment, as people who are classified as 'high-risk' can receive more targeted therapy. Having a better understanding of the genetic makeup of the tumours means that the most effective chemotherapy drug can be used.

The researchers made their predictions in people with breast and lung cancer, but they hope their findings can be extended to other forms of cancer.

Professor Pan-Chyr Yang of National Taiwan University said: 'The eight-gene signature obtained here may help choice of treatment as part of individualised cancer therapy and our method of gene discovery may be applicable in studying other cancers'.

The researchers acknowledged that the cancer cells in the body may react differently to the cell lines they tested, saying: 'There is room to improve our eight-gene signature for drug-sensitivity prediction [...] Other genomic components, such as DNA copy number, single nucleotide polymorphisms, methylation and microRNA, have not been considered in our study'.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE
26 September 2016 - by Ebtehal Moussa 
A new gene therapy technique using microRNAs has successfully prevented the spread of breast cancer in mice...
5 October 2015 - by Dr Nicola Davis 
A genetic test that can identify women with early-stage breast cancer who can be spared unnecessary treatment with chemotherapy has been shown to be effective in a clinical study...
13 April 2015 - by Dr Nicoletta Charolidi 
A new type of cancer vaccine that enriches the immune system with tailor-made anti-tumour antibodies has shown early signs of promise...
1 December 2014 - by Dr Anna Cauldwell 
Genetics researchers in the US have identified mutations that significantly increase the likelihood that an individual will go on to develop blood cancer...
3 November 2014 - by Jenny Sharpe 
Genetic factors could explain why some people survive the Ebola virus, a study in the USA suggests...
18 March 2013 - by Sarah Pritchard 
Stem cells taken from patients' own fat tissue could potentially be used to deliver treatments direct to brain tumours, say scientists after early laboratory tests...
5 November 2012 - by Dr Greg Ball 
Banked sperm-producing stem cells have been used to restore sperm production in monkeys made infertile by chemotherapy treatment...
15 May 2012 - by Antony Starza-Allen 
Stem cells transplanted into the brain may offer protection against the side effects of chemotherapy, say US researchers...
26 March 2012 - by Sarah Pritchard 
A genetic test could be used to spare breast cancer patients from having to undergo postoperative chemotherapy...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.